Dow Down 0.26% Nasdaq Down 0.37%

More On THR.BR

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

ThromboGenics NV (THR.BR)

-Brussels
7.39 Down 0.04(0.54%) 11:35AM EDT
Prev Close:7.43
Open:7.42
Bid:7.36
Ask:7.44
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:7.33 - 7.45
52wk Range:7.33 - 24.00
Volume:61,403
Avg Vol (3m):112,724
Market Cap:266.73M
P/E (ttm):N/A
EPS (ttm):-1.45
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in EUR.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):15.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-11) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ThromboGenics NV, an integrated biopharmaceutical company, is engaged in developing and commercializing ophthalmic and oncology medicines in Belgium and interntionally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback